We learned from the Shanghai Science and Technology Commission that on July 13, the first prescription was issued in Shanghai after the implantable brain-computer interface hand motor function compensation system was approved for marketing, and the world's first implant surgery was completed at Huashan Hospital affiliated to Fudan University. Intraoperative tests showed that the epidural EEG signals collected by the system were stable and of good quality. Currently, the patient's vital signs are stable after surgery. From being approved for marketing on March 13 to entering actual diagnosis and treatment four months later, it is a medical product that was once limited to cutting-edge technology in laboratories and clinical trials, thus becoming a medical product that eligible patients can evaluate and use.

We learned from the Shanghai Science and Technology Commission that on July 13, the first prescription was issued in Shanghai after the implantable brain-computer interface hand motor function compensation system was approved for marketing, and the world's first implant surgery was completed at Huashan Hospital affiliated to Fudan University. Intraoperative tests showed that the epidural EEG signals collected by the system were stable and of good quality. Currently, the patient's vital signs are stable after surgery. From being approved for marketing on March 13 to entering actual diagnosis and treatment four months later, it is a medical product that was once limited to cutting-edge technology in laboratories and clinical trials, thus becoming a medical product that eligible patients can evaluate and use.